[go: up one dir, main page]

AU2001270451A1 - Memory-enhancing peptides and the use thereof - Google Patents

Memory-enhancing peptides and the use thereof

Info

Publication number
AU2001270451A1
AU2001270451A1 AU2001270451A AU7045101A AU2001270451A1 AU 2001270451 A1 AU2001270451 A1 AU 2001270451A1 AU 2001270451 A AU2001270451 A AU 2001270451A AU 7045101 A AU7045101 A AU 7045101A AU 2001270451 A1 AU2001270451 A1 AU 2001270451A1
Authority
AU
Australia
Prior art keywords
memory
enhancing peptides
peptides
enhancing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001270451A
Inventor
Yucang Du
Jinhuan Shen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai CAS Intide Biotech Co Ltd
Original Assignee
SHANGHAI CAS INTIDE BIOTECH CO
Shanghai CAS Intide Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANGHAI CAS INTIDE BIOTECH CO, Shanghai CAS Intide Biotech Co Ltd filed Critical SHANGHAI CAS INTIDE BIOTECH CO
Publication of AU2001270451A1 publication Critical patent/AU2001270451A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2001270451A 2000-06-30 2001-05-28 Memory-enhancing peptides and the use thereof Abandoned AU2001270451A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN00116876 2000-06-30
CNB001168762A CN1154656C (en) 2000-06-30 2000-06-30 Memory-improving peptides and their application
PCT/CN2001/000875 WO2002002592A1 (en) 2000-06-30 2001-05-28 Memory-enhancing peptides and the use thereof

Publications (1)

Publication Number Publication Date
AU2001270451A1 true AU2001270451A1 (en) 2002-01-14

Family

ID=4586275

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001270451A Abandoned AU2001270451A1 (en) 2000-06-30 2001-05-28 Memory-enhancing peptides and the use thereof

Country Status (6)

Country Link
US (1) US7119063B2 (en)
EP (1) EP1300416B1 (en)
JP (1) JP4372417B2 (en)
CN (1) CN1154656C (en)
AU (1) AU2001270451A1 (en)
WO (1) WO2002002592A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109265514B (en) * 2018-09-28 2021-03-30 华南理工大学 A kind of improving memory peptide with resistance to gastrointestinal tract digestion and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56021B1 (en) * 1982-10-13 1991-03-27 Akzo Nv Peptides
IE58407B1 (en) * 1984-04-13 1993-09-22 Akzo Nv Peptides
KR0141693B1 (en) * 1988-08-12 1998-06-15 나까무라 하루후미 Peptide Derivatives and Antidementants
ATE113606T1 (en) * 1989-04-15 1994-11-15 Nippon Chemiphar Co PEPTIDES AND AGENTS CONTAINING THESE PEPTIDES AGAINST DEMENTIA.
CN1036010C (en) * 1992-08-08 1997-10-01 中国科学院上海生物化学研究所 Memory enhancing peptide and its application

Also Published As

Publication number Publication date
US20040116656A1 (en) 2004-06-17
JP4372417B2 (en) 2009-11-25
EP1300416A4 (en) 2007-08-22
WO2002002592A1 (en) 2002-01-10
CN1154656C (en) 2004-06-23
EP1300416A1 (en) 2003-04-09
US7119063B2 (en) 2006-10-10
CN1331083A (en) 2002-01-16
JP2004527454A (en) 2004-09-09
EP1300416B1 (en) 2012-07-11

Similar Documents

Publication Publication Date Title
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
EP1414848A4 (en) Replikin peptides and uses thereof
AU2002211717A1 (en) Stresscopins and their uses
EP1419175A4 (en) Replikin peptides and uses thereof
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU4776800A (en) Acetylcholinesterase-derived peptides and uses thereof
AU2001264852A1 (en) Lactobacillusbeta -glucuronidase and dna encoding the same
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU5994599A (en) Rbp1 polypeptides and uses thereof
GB0026134D0 (en) Peptides and their use
AU2001276258A1 (en) Ceramic component and the use thereof
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU2001277519A1 (en) Bio-probes and use thereof
AU2001270451A1 (en) Memory-enhancing peptides and the use thereof
AU2001294267A1 (en) Survivin-like polypeptides and dnas thereof
AU2001278975A1 (en) Alpha-conotoxin peptides
AU2001233333A1 (en) Par4 peptides and polypeptides
AU4328500A (en) Retro-inverso prosaposin-derived peptides and use thereof
AU2002215312A1 (en) Human proteases and polynucleotides encoding the same
AU2001293084A1 (en) Human protease inhibitor proteins and polynucleotides encoding the same
AU2002227496A1 (en) Polynucleotides and polypeptides
AU2001250047A1 (en) Effector-specific protein assembly and uses thereof
AUPR589701A0 (en) Novel peptide and use thereof
SG10201403662QA (en) Replikin peptides and uses thereof
AU2001272919A1 (en) Lp120 polypeptides and therapeutic uses thereof